Beta3-adrenoceptors in the rat sacral spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction

Neurourology and Urodynamics

Volumn 30, Issue 7, 2011, Pages 1382-1387

  Füllhase, Claudius ^a,b   Soler, Roberto ^a,c   Westerling Andersson, Kristian ^a   Andersson, Karl Erik ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

benign prostatic hyperplasia; beta3 adrenoreceptor agonist; cystometry; intrathecal; overactive bladder

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; CONTROLLED STUDY; CYSTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MICTURITION; MORPHOMETRICS; NONHUMAN; PROTEIN EXPRESSION; RAT; SACRAL SPINAL CORD; URETHRA OBSTRUCTION; URODYNAMICS;

ADRENERGIC BETA-3 RECEPTOR AGONISTS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ETHANOLAMINES; IMMUNOHISTOCHEMISTRY; MALE; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-3; SACRUM; SPINAL CORD; TIME FACTORS; UP-REGULATION; URETHRAL OBSTRUCTION; URINARY BLADDER; URINATION; URODYNAMICS;

EID: 80052071598     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21071     Document Type: Article

References (30)

1. de Groat WC,. Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 2006; 147: S25-40. (Pubitemid 43237573)
2. Kanai A, Andersson KE,. Bladder afferent signaling: recent findings. J Urol 2010; 183: 1288-95.
3. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE,. A Refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol 2009. 56: 810-9.
4. Chapple C, Wyndaele JJ, Van Kerrebroeck P, Radziszewski P, Dvorak V, Boerrigter P,. 774 Dose-ranging study of once-daily mirabegron (YM178), a novel selective [beta]3-adrenoceptor agonist, in patients with overactive bladder (OAB). Eur Urol 2010; (Suppl 9): 249.
5. Masunaga K, Chapple CR, McKay NG, Yoshida M, Sellers DJ,. The beta(3)-adrenoceptor mediates the inhibitory effects of beta-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn 2010; 29: 1320-5.
6. Michel MC, Vrydag W,. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 2006; 147: S88-119. (Pubitemid 43237577)
7. Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ,. Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 2010; 29: 771-6.
8. Rodriguez M, Carillon C, Coquerel A, Le Fur G, Ferrara P, Caput D, Shire D,. Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain. Brain Res Mol Brain Res 1995; 29: 369-75.
9. Summers RJ, Papaioannou M, Harris S, Evans BA,. Expression of beta 3-adrenoceptor mRNA in rat brain. Br J Pharmacol 1995; 116: 2547-8.
10. Ursino MG, Vasina V, Raschi E, Crema F, De Ponti F,. The beta3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res 2009; 59: 221-34.
11. JC Garber RB, Bielitzki JT, Clayton LA, Donnovan JC, Kohn DF, Lipman NS, Locke P, Melcher J, Quimby FW, Turner PV, Wood GA, Würbel H,. The Guide for the Care and Use of Laboratory Animals. Committee for the update of the Guide for the Care and Use of Laboratory Animals DoEaLS, and the National Research Council, editor. Washington, D.C.: The National Academies Press; 2010.
12. Melman A, Tar M, Boczko J, Christ G, Leung AC, Zhao W, Russell RG,. Evaluation of two techniques of partial urethral obstruction in the male rat model of bladder outlet obstruction. Urology 2005; 66: 1127-33. (Pubitemid 41587188)
13. Knobler RL,. Vacuolar reaction in the spinal cord following intracardiac fluorocarbon-glutaraldehyde-formaldehyde perfusion: preliminary report. Fed Proc 1975; 34: 1515.
14. Molander C, Xu Q, Grant G,. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol 1984; 230: 133-41. (Pubitemid 15221509)
15. Meikle AD, Martin AH,. A rapid method for removal of the spinal cord. Stain Technol 1981; 56: 235-7. (Pubitemid 12226098)
16. Malmgren A, Sjogren C, Uvelius B, Mattiasson A, Andersson KE, Andersson PO,. Cystometrical evaluation of bladder instability in rats with infravesical outflow obstruction. J Urol 1987; 137: 1291-4. (Pubitemid 17079086)
17. Yaksh TL, Rudy TA,. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6. (Pubitemid 8063691)
18. Fullhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE,. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction. J Urol 2010; 184: 783-9.
19. Soler R, Fullhase C, Santos C, Andersson KE,. Development of bladder dysfunction in a rat model of dopaminergic brain lesion. Neurourol Urodyn 2011; 30: 188-93.
20. Steers WD, Ciambotti J, Erdman S, de Groat WC,. Morphological plasticity in efferent pathways to the urinary bladder of the rat following urethral obstruction. J Neurosci 1990; 10: 1943-51.
21. Steers WD, Ciambotti J, Etzel B, Erdman S, de Groat WC,. Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction. J Comp Neurol 1991; 310: 401-10.
22. Steers WD, De Groat WC,. Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J Urol 1988; 140: 864-71.
23. de Groat WC, Fraser MO, Yoshiyama M, Smerin S, Tai C, Chancellor MB, Yoshimura N, Roppolo JR,. Neural control of the urethra. Scand J Urol Nephrol 2001; 207: 35-43. (Pubitemid 32472655)
24. Nadelhaft I, Vera PL,. Separate urinary bladder and external urethral sphincter neurons in the central nervous system of the rat: simultaneous labeling with two immunohistochemically distinguishable pseudorabies viruses. Brain Res 2001; 903: 33-44. (Pubitemid 32904604)
25. Shafik A, el-Sibai O, Ahmed I,. Effect of urethral dilation on vesical motor activity: identification of the urethrovesical reflex and its role in voiding. J Urol 2003; 169: 1017-9. (Pubitemid 36188148)
26. Yoshimura N, Seki S, Erickson KA, Erickson VL, Chancellor MB, de Groat WC,. Histological and electrical properties of rat dorsal root ganglion neurons innervating the lower urinary tract. J Neurosci 2003; 23: 4355-61. (Pubitemid 36958456)
27. Chalfin SA, Bradley WE,. The etiology of detrusor hyperreflexia in patients with infravesical obstruction. J Urol 1982; 127: 938-42. (Pubitemid 12124254)
28. Barendrecht MM, Frazier EP, Vrydag W, Alewijnse AE, Peters SL, Michel MC,. The effect of bladder outlet obstruction on alpha1- and beta-adrenoceptor expression and function. Neurourol Urodyn 2009; 28: 349-55.
29. Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, Andersson KE,. Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 1999; 126: 819-25. (Pubitemid 29087864)
30. Nomiya M, Yamaguchi O,. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 2003; 170: 649-53. (Pubitemid 36870277)